[ 8 ] Rupp ME, Lisco SJ, Lipsett PA, et al. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial[J]. Ann Intern Med, 2005, 143(8): 570-580.
[3]
[ 9 ] Powe NR, Jaar B, Furth SL, et al. Septicemia in dialysis patients: incidence, risk factors, and prognosis[J]. Kidney Int, 1999, 55(3): 1081-1090.
[4]
Allon M. Dialysis catheter-related bacteremia: treatment and prophylaxis[J]. Am J Kidney Dis, 2004, 44(5): 779-791.
[5]
Kleven RM, Edwards JR, Andrus ML, et al. Dialysis surveillance report: national healthcare safety network (NHSN)-data summary for 2006[J]. Semin Dial, 2008, 21(1): 24-28.
[6]
Yahav D, Rozen-Zvi B, Gafter-Gvili A, et al. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials[J]. Clin Infect Dis, 2008, 47(1): 83-93.
Watanabe H, Masaki H, Asoh N, et al. Emergence and spread of low-level mupirocin resistance in methicillin-resistant staphylococcus aureus isolated from a community hospital in Japan[J]. J Hosp Infect, 2001, 47(4): 294-300.
[ 4 ] Maya ID, Allon M. Vascular access: core curriculum 2008[J]. Am J Kidney Dis, 2008, 51(4): 702-708.
[17]
[ 5 ] Spergel LM. Has the fistula first breakthrough initiative caused an increase in catheter prevalence[J]. Semin Dial, 2008, 21(6): 550-552.
[18]
[ 6 ] Ethier J, Mendelssohn DC, Elder SJ, et al. Vascular access use and outcomes: an international perspective from the dialysis outcomes and practice patterns study[J]. Nephrol Dial Transplant, 2008, 23(10): 3219-3226.